AI-generated summary
The authors report a randomized controlled trial of 830 nm laser applied to the palm and acupoints ST 36 and KI 1 in 40 hemodialysis patients. After treatment, sleep and quality-of-life scores improved and pain decreased, and the authors suggest the approach could be a complementary option.
- Participants
- 40
- Who or what was studied
- Patients with end-stage renal disease undergoing hemodialysis
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract does not describe a control group comparison in detail, and the sample of 40 patients is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Energy density (fluence)
- 256.10 J/cm2, 109.76 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Randomized controlled trial, Photobiomodulation, Dose, Visual analogue scale, Insomnia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.